Skip to main content

Table 1 Clinical information of patients with hepatocellular carcinoma in three datasets

From: An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients

Characteristics

TCGA (N = 319)

ICGC (N = 232)

GSE76427 (N = 94)

Age (years) (%)

 ≤ 60

160 (50.2)

49 (21.1)

43 (45.7)

 > 60

159 (49.8)

183 (78.9)

51 (54.3)

Gender (%)

 Female

100 (31.3)

61 (26.3)

12 (12.8)

 Male

219 (68.7)

171 (73.7)

82 (87.2)

Grade (%)

 G1

44 (13.8)

NA

NA

 G2

154 (48.3)

NA

NA

 G3

109 (34.1)

NA

NA

 G4

12 (3.8)

NA

NA

AJCC stage (%)

 Stage I

160 (50.2)

36 (15.5)

41 (43.6)

 Stage II

76 (23.8)

104 (44.8)

31 (33.0)

 Stage III

80 (25.1)

73 (31.5)

19 (20.2)

 Stage IV

3 (0.9)

19 (8.2)

3 (3.2)

Survival status (%)

 Alive

215 (67.4)

189 (81.5)

74 (78.7)

 Deceased

104 (32.6)

43 (18.5)

20 (21.3)